News
-
Terry Guido Featured in The Wall Street Journal
Marquis Who's Who proudly endorsed Terry Guido in the Western Edition of The Wall Street Journal -
Sara J. McKenzie, PhD, MBA, Featured in The Wall Street Journal
Marquis Who's Who proudly endorsed Sara J. McKenzie, PhD, MBA, in the Western Edition of The Wall Street Journal -
AdvantaPure™ Announces Full USP 665 Compliance
Regulatory standards transition with full compliance mandated by May 1, 2026 -
Marquis Who's Who Honors Peter Wilkinson for Leadership in Bioinformatics and Digital Laboratory Innovation
Peter Wilkinson is recognized for pioneering work at the intersection of immunology, bioinformatics, and advanced computing, transforming laboratories and clinical programs into digital, data-driven enterprises. -
Stacian A. Reynolds, MHA, MLS(ASCP)CM Honored for Expertise in the Field of Health Care
Stacian A. Reynolds, MHA, MLS(ASCP)CM celebrated for more than 15 years of professional success -
Tropical Oasis Names Dr. Lauren Ramsey Clinical Ambassador, Strengthening the Brand's Science-First Mission
Board-certified surgeon and long-time Tropical Oasis customer will guide research, product development, and family-focused education. -
Marquis Who's Who Honors Niranjana Raghunathan for Expertise in Laboratory Information Management Systems
Niranjana Raghunathan is recognized for her contributions to GSK plc in advancing systems and enhancing research -
Creative Biolabs Advances Global CAR‑T Development with Integrated CDMO Solutions
Creative Biolabs launches a comprehensive CDMO solutions to match the exact needs of CAR-T cell therapies. -
Alfa Cytology Unveils Endogenous T-cell Engagement System Platform to Power Up Tumor Immunotherapy
Alfa Cytology today unveils its innovative endogenous T-cell engagement system (ETES™) platform. -
New mRNA Platform From Creative Biolabs to Accelerate Therapeutics and iPSC Reprogramming
Creative Biolabs launches an advanced mRNA platform integrating in silico structural prediction and polymer-based delivery development to accelerate mRNA therapeutics and iPSC reprogramming.